SCHEMBL12863003

SCHEMBL12863003

COC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)C(C)(C)C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM4 O15151 1/20 0.60
MDM2 Q00987 1/20 0.60
NPSR1 Q6W5P4 2/20 0.57
KMT2A Q03164 1/20 0.57
LNPEP Q9UIQ6 3/20 0.56
TSHR P16473 1/20 0.56
GRIA1 P42261 1/20 0.54
ESR1 P03372 1/20 0.54
ESR2 Q92731 1/20 0.54
NLRP3 Q96P20 1/20 0.52
ALDH1A1 P00352 2/20 0.50
MIF P14174 1/20 0.50
KDR P35968 1/20 0.49
ATM Q13315 1/20 0.48
ERAP2 Q6P179 2/20 0.47
ERAP1 Q9NZ08 1/20 0.47
LCK P06239 1/20 0.47
THRB P10828 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28883406 0.87 NOS2 (0.55) MDM4MDM2KMT2AALDH1A1ATM
SCHEMBL28582286 0.87 MDM4 (0.58) MDM4MDM2NPSR1KMT2ALNPEP
SCHEMBL6510996 0.87 LNPEP (0.49) MDM4MDM2NPSR1KMT2ALNPEP
SCHEMBL28883318 0.87 NOS2 (0.61) MDM4MDM2KMT2ATSHRALDH1A1
SCHEMBL28883302 0.87 NPSR1 (0.56) MDM4MDM2NPSR1KMT2ATSHR
SCHEMBL28582287 0.87 MDM4 (0.58) MDM4MDM2NPSR1KMT2ALNPEP
SCHEMBL12863012 0.87 ATM (0.63) MDM4MDM2KMT2AALDH1A1ATM
SCHEMBL11940456 0.87 ATM (0.63) MDM4MDM2KMT2AALDH1A1ATM
SCHEMBL20211752 0.87 ATM (0.63) MDM4MDM2KMT2AALDH1A1ATM
SCHEMBL28883295 0.86 ALDH1A1 (0.48) MDM4MDM2NPSR1KMT2ALNPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110028509-A1 Sulfonamides MERCK SERONO SA (CH) 2011-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028509-A1 Sulfonamides CXCR3, CXCR2, CXCR1 MDM4 3549/4885MDM2 2877/4885NPSR1 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.